Lotemax Suspension/ Drops
Product Images NDC 24208-299

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lotemax (NDC 24208-299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

503e8dec 527b 419a 858d Ef038ce3cf5e 00

This is a description of an eye product called Lotemax Sterile Ophthalmic Suspension, containing Loteprednol Etabonate 0.5% as the active ingredient and additional inactive ingredients, such as Disodium Edetate and Glycerin. It also contains Preservative Ade: Berzalionm Gloride 0.01%, and the recommended dosage is as per the package insert. The product is manufactured by Bausch & Lomb Incorporated in Tampa, Florida, and distributed by Bausch + Lomb in Bridgewater, New Hampshire. The text also includes instructions for use, warnings, and storage information. *

FDA Label Image

Loteprednol Etabonate (structural Formula) (760eeae1 6004 4314 9b29 1f7d434714cf 01)

FDA Label Image

Symbol (760eeae1 6004 4314 9b29 1f7d434714cf 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.